China Blocks Pharmaceutical Merger in Rare Antitrust Move

July 23, 2025 – Beijing China’s State Administration for Market Regulation (SAMR) has blocked the proposed acquisition of a 50% stake in Shandong Beida Gaoke Huatai Pharmaceutical Co., Ltd. (Shandong Huatai Pharmaceutical) by Wuhan Yongtong […]

Competition Today

FREE
VIEW